Hackensack, New Jersey Clinical Trials

A listing of Hackensack, New Jersey clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 264 clinical trials
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

The primary objective of this study is to demonstrate the non-inferiority of the vaccine seroresponse to meningococcal serogroups A, C, Y, and W following administration of 2 doses of MenACYW conjugate vaccine compared to 2 doses of MENVEO when given concomitantly with routine pediatric vaccines to infants and toddlers 6 …

Investigational Site Number 8400069
 (8.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +47 other locations
Phase 2 Study of SAR439859 Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer (AMEERA-3)

Primary Objective: To determine whether SAR439859 per os improves progression free survival (PFS) when compared with a endocrine monotherapy of the choice of the physician, in participants with metastatic or locally advanced breast cancer. Secondary Objectives: To compare the overall survival in the 2 treatment arms To assess the objective …

HER2
stage iv breast cancer
breast cancer
estrogen receptor
adjuvant
Investigational Site Number 8400025
 (0.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +130 other locations
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis (FREVIVA)  

The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the disability progression and the safety up to approximately 51 months administration of study intervention compared to placebo in male and female participants with nrSPMS (aged 18 to 60 years at …

Holy Name Medical Center Site Number : 8400101
 (2.0 away)
  • 0 views
  • 04 Mar, 2025
  • +58 other locations
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma (AIRLYMPUS)

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this study is to assess the efficacy, safety, and tolerability of add-on therapy with SC lunsekimig compared with placebo in male and female participants (aged 18 to 80 years, inclusive) with asthma, …

Icahn School of Medicine at Mount Sinai - Mount Sinai Health System- Site Number : 8400069
 (8.6 away) Contact site
  • 0 views
  • 24 Nov, 2025
  • +50 other locations
A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV

Many people living with HIV (PLWH) smoke. Smoking in these individuals is often undertreated. This study plans to assess the ability of various clinical pathways involving tobacco treatment medications and contingency management (paying smokers for not smoking) to improve smoking cessation in a group of PLWH.

smoking cessation therapy
tobacco use disorder
Icahn School of Medicine at Mount Sinai
 (8.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer

Patients with metastatic prostate cancer can undergo MRI-guided prostate Stereotactic body radiation therapy (SBRT) without significant adverse events, similar to what has been reported for patients with localized prostate cancer. We hypothesize that prostate SBRT will be well-tolerated in metastatic prostate cancer patients, with quality of life outcomes similar to …

stereotactic body radiation therapy
MRI
non-metastatic prostate cancer
metastatic prostate cancer
adenocarcinoma
Weill Cornell Medicine
 (9.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
CIMER: Combined Immunotherapies in Metastatic ER+ Breast Cancer

Women with Hormone Receptor (HR)+ Human Epidermal growth factor Receptor (HER)2- metastatic breast cancer are eligible to a randomized trial. Patients receiving standard first line therapy for metastatic HR+ Breast cancer(BC) (letrozole+palbociclib) are randomly assigned to also receive Stereotactic Body Radiation Therapy(SBRT) to each metastatic lesion.

HER2
estradiol
stage iv breast cancer
epidermal growth factor receptor
stereotactic body radiation therapy
Weill Cornell Medicine
 (9.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Trial With the Treatment of Sertraline in Youth With Generalized Separation and/or Social Anxiety Disorders.

A Multicenter, acute, randomized, double-blind, placebo-controlled, flexible-dose trial with the treatment of sertraline.

psychosis
estrogen
progestin
adjustment disorder
sertraline
University of Columbia, New York State Psychiatric Institute
 (6.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Using Direct Brain Stimulation to Study Cognitive Electrophysiology

This project forms a multi-site research collaboration to carry out verbal and spatial memory experiments in patient volunteers to better understand the neural bases of human memory, employing direct electrical brain stimulation as a tool to study those dynamics and their relationship to memory performance.

epilepsy
electrical stimulation
brain stimulation
Columbia University
 (6.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations
Hypofractionated Radiotherapy in Elderly Patients With Head & Neck Squamous Cell Carcinoma

The purpose of this research study is to investigate a shorter radiation treatment schedule for head and neck cancers in patients 70 years of age and older. Standard radiation treatment for head and neck patients normally requires that the patient travel to the hospital daily for 6-7 weeks to receive …

Mount Sinai Hospital
 (8.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations